New PET scans to detect ovarian cancer recurrence
Treatments studied
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ovarian cancer and have had a good response to treatment (complete remission).
- You are between 30 and 80 years old.
- Your CA-125 blood test is higher than 35 U/mL or has doubled from your normal level after treatment.
- You are in good enough health to handle daily activities (ECOG 0 or 1) and willing to get more treatment if needed.
- You are not pregnant, breastfeeding, or allergic to the imaging agents used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of imaging scan called 68Ga-FAPI-PSMA PET that may help doctors better detect and diagnose solid tumors like prostate, liver, ovarian, or endometrial cancer. You would receive the scan before having a biopsy or surgery.
This trial uses PET-CT scans to create a model that predicts how completely advanced ovarian cancer can be removed during surgery. It may help doctors plan the best treatment for you.
This study tests a special imaging agent (89Zr-DFO-Mirvetuximab) that may help doctors see ovarian cancer more clearly on PET/CT scans. It is for people with advanced or recurring ovarian cancer to assess if the drug is safe and effective for imaging.
This trial uses a new kind of PET/CT scan to take detailed pictures of solid tumors such as melanoma, liver, lung, breast, pancreatic, or ovarian cancer. The scan might help doctors find cancer more clearly.
This trial tests a new type of PET scan called Ga-68-FAPI-46 to help find if your colorectal cancer has returned when your CEA levels are rising. It might offer a more accurate way to detect recurrence early.
This pilot study uses a special PET/CT scan (with a radioactive tracer) to help doctors better “stage” high-grade epithelial ovarian cancer—especially when it’s advanced. The goal is to see whether the scan can improve planning for treatment like surgery or chemotherapy first.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.